Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 15 May 2014 | By Alexander Gaffney, RAC,
The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) has proposed that two medical devices marketed prior to the 1976 Medical Device Amendments to the Federal Food, Drug and Cosmetic Act (FD&C Act) be subject to less stringent regulation.
In two separate Federal Register announcements, FDA said it would permit intravascular administration sets and colon capsule imaging systems, respectively, to be classified as Class II devices under the FD&C Act.
The devices, having been approved prior to the Medical Device Amendments, had been classified as Class III—high risk—devices subject to premarket approval (PMA) requirements.
Under the new classifications, they will be subject to premarket notification requirements [510(k)] along with general controls and special controls meant to ensure that they are safe and effective, but without the need to conduct extensive clinical trials.
Both orders will be made final 30 days after 16 May 2014.
Medical Devices: Classification of the Colon Capsule Imaging System
Medical Devices: Classification of the Intravascular Administration Set, Automated Air Removal System
Tags: CDRH, Medical Device, Device Reclassification, Final Rule, Class II, Down-classification
Regulatory Focus newsletters
All the biggest regulatory news and happenings.